Our Pricing

Prescription Diet Injections UK - Order Weight Loss Treatment

Searching for prescription diet injections UK online with transparent pricing and expert clinical support? At Cured Pharmacy, our UK-registered clinical team provides access to licensed GLP-1 treatments including Mounjaro, Wegovy, and Saxenda, with prices from £135.00 and free online consultations completed in under three minutes. Every prescription diet injection requires assessment by a UK prescriber to ensure safety and suitability for your individual health profile.

How Prescription Diet Injections Work in the UK

Prescription diet injections available in the UK primarily work through GLP-1 (glucagon-like peptide-1) receptor pathways, mimicking natural hormones that regulate appetite, blood sugar, and gastric emptying [1]. These medications—including tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda)—are licensed by the MHRA for weight management in adults with a BMI of 30 or above, or 27 with weight-related health conditions.

Mounjaro represents the latest advancement as a dual GIP/GLP-1 receptor agonist, activating two complementary pathways rather than one [2]. In the SURMOUNT-1 trial, participants using the 15mg dose achieved an average body weight reduction of 22.5% over 72 weeks, significantly outperforming earlier single-pathway treatments [2]. Wegovy (semaglutide) demonstrated average weight loss of 14.9% in the STEP 1 trial, while Saxenda (liraglutide) showed mean reductions of 8% in clinical studies [3][4].

These injections work by slowing gastric emptying, reducing hunger signals to the brain, and improving glycaemic control—effects that support sustainable weight management when combined with dietary modifications and physical activity [1]. All prescription diet injections require ongoing clinical monitoring by a UK healthcare professional to assess efficacy and manage potential side effects.

Comparing Prescription Diet Injections UK: Mounjaro, Wegovy & Saxenda

UK patients now have access to three primary prescription diet injections, each with distinct mechanisms, dosing schedules, and clinical profiles. Understanding these differences helps inform discussions with your prescriber about the most suitable option for your circumstances.

Mounjaro (tirzepatide) offers the most recent innovation with dual receptor activation, administered once weekly via pre-filled KwikPen injectors. The treatment follows a gradual dose escalation protocol starting at 2.5mg, with maintenance doses ranging from 5mg to 15mg depending on individual response and tolerability [2]. Clinical trials demonstrate superior weight reduction compared to single-pathway alternatives, though it carries a higher initial cost.

Wegovy (semaglutide) provides once-weekly subcutaneous injections starting at 0.25mg, escalating to a maintenance dose of 2.4mg over 16-20 weeks. The STEP clinical programme showed sustained weight loss with good tolerability profiles when patients adhered to the gradual titration schedule [3]. Wegovy shares the same active ingredient as Ozempic but is specifically licensed and dosed for weight management rather than diabetes treatment.

Saxenda (liraglutide) requires daily subcutaneous injections, starting at 0.6mg and increasing to a maintenance dose of 3mg. Whilst the daily administration demands greater commitment, Saxenda offers a lower entry price point and has the longest clinical track record among GLP-1 weight management treatments in the UK [4]. Some patients prefer the daily dosing for more consistent appetite control throughout the week.

Choosing Between Weekly and Daily Injections

The choice between weekly injections (Mounjaro, Wegovy) and daily administration (Saxenda) often depends on lifestyle preferences, previous medication adherence patterns, and individual response to treatment. Weekly injections offer convenience and may improve long-term adherence, whilst daily dosing provides more frequent touchpoints that some patients find psychologically supportive. Your UK prescriber will assess your medical history, current medications, and weight management goals to recommend the most appropriate prescription diet injection for your circumstances.

Clinical Efficacy: What the Evidence Shows

Robust clinical trial data underpins the use of prescription diet injections in the UK, with regulatory approval from the MHRA based on demonstrated safety and efficacy in large-scale studies. Understanding this evidence helps set realistic expectations for treatment outcomes.

The SURMOUNT-1 trial enrolled 2,539 adults without diabetes, randomising participants to tirzepatide (5mg, 10mg, or 15mg) or placebo, alongside lifestyle interventions. At 72 weeks, the 15mg tirzepatide group achieved mean weight reduction of 22.5% compared to 2.4% in the placebo group—a clinically significant difference that exceeded primary endpoints [2]. Importantly, 91% of participants on the highest dose achieved at least 5% weight loss, meeting the threshold associated with cardiovascular and metabolic health improvements.

The STEP 1 trial examined semaglutide 2.4mg (Wegovy) in 1,961 adults, demonstrating mean body weight reduction of 14.9% versus 2.4% with placebo over 68 weeks [3]. Secondary endpoints including waist circumference, blood pressure, and lipid profiles showed statistically significant improvements, supporting the broader metabolic benefits beyond weight reduction alone.

Real-world outcomes may vary from controlled trial settings, with factors including adherence, dietary modifications, physical activity levels, and individual metabolic responses influencing results. NICE guidance emphasises that prescription diet injections should form part of a comprehensive weight management programme rather than standalone therapy [5].

Prescription Diet Injections UK: Pricing and Access at Cured Pharmacy

Transparent pricing remains a priority at Cured Pharmacy, with costs displayed upfront before you complete your clinical assessment. Prescription diet injections start from £135.00 for Saxenda, with Wegovy available from £135.00 and Mounjaro from £135.00 depending on prescribed dose and supply duration.

Unlike some online providers, Cured Pharmacy shows exact pricing before consultation, eliminating surprise costs after prescriber approval. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees dispensing of all prescription medications, ensuring every treatment meets MHRA licensing standards and originates from UK-licensed wholesalers. We guarantee the lowest prices in the UK market—if you find a lower price for the same product and dose from a registered UK pharmacy, we'll match it.

All prescription diet injections require completion of a free online consultation, reviewed by our UK-registered prescribers typically within 24 hours. The assessment covers your medical history, current medications, weight management goals, and any contraindications to GLP-1 therapy. Subject to prescriber approval, your medication is dispensed from our GPhC-registered pharmacy (9012511) and delivered in 100% discreet packaging via tracked courier services.

We offer flexible supply options including 28-day and 84-day prescriptions, with automatic reminders before your supply runs out to support treatment continuity. Payment plans are not currently available, but our competitive pricing structure ensures prescription diet injections remain accessible compared to typical UK market rates.

What's Included in Your Treatment Cost

Your prescription diet injection price includes the medication itself, clinical assessment by a UK prescriber, dispensing by our registered pharmacy team, and discreet home delivery with tracking. Follow-up consultations for dose adjustments or treatment reviews are provided at no additional charge, ensuring ongoing clinical oversight throughout your weight management journey. Injection supplies (needles, alcohol swabs) are included with Saxenda; Mounjaro and Wegovy use pre-filled single-use pens requiring no additional supplies.

Side Effects and Safety Considerations

All prescription diet injections carry potential side effects, predominantly gastrointestinal in nature due to their mechanism of slowing gastric emptying. Understanding these effects and management strategies supports treatment adherence and safety.

The most commonly reported side effects across GLP-1 treatments include nausea (affecting 20-44% of patients), diarrhoea, constipation, vomiting, and abdominal discomfort [2][3][4]. These effects typically occur during initial dosing and dose escalation phases, often diminishing as the body adapts to treatment. Gradual titration schedules are specifically designed to minimise gastrointestinal symptoms whilst achieving therapeutic doses.

More serious but rare adverse events include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking concurrent diabetes medications). The MHRA requires prescribers to assess risk factors including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, both of which contraindicate GLP-1 therapy [1]. Patients should report severe abdominal pain, persistent vomiting, or signs of allergic reaction to their healthcare provider immediately.

Pregnancy and breastfeeding represent absolute contraindications to prescription diet injections, with treatment discontinued at least two months before planned conception due to unknown foetal effects [5]. Our UK prescribers conduct thorough assessments to identify contraindications and ensure safe prescribing aligned with MHRA guidance and current clinical evidence.

Starting Your Prescription Diet Injection Treatment

Beginning treatment with prescription diet injections UK requires clinical assessment, proper injection technique, and realistic goal-setting supported by your healthcare team. Cured Pharmacy streamlines this process whilst maintaining rigorous clinical standards.

Your journey starts with our free online consultation, accessible 24/7 via desktop or mobile devices. The assessment takes under three minutes to complete and covers essential medical information including current weight, height, previous weight loss attempts, existing health conditions, and current medications. Our UK-registered prescribers review your submission, typically within 24 hours, and may request additional information if needed to ensure safe prescribing.

Once approved, you'll receive detailed injection instructions alongside your medication. Mounjaro and Wegovy use pre-filled pens with simple push-button mechanisms, requiring no manual needle attachment. Saxenda pens allow dose adjustment via a dial mechanism. Injection sites include the abdomen, thigh, or upper arm, rotated to prevent lipohypertrophy. Most patients report minimal discomfort, with injection-site reactions (redness, itching) affecting fewer than 5% of users [4].

Successful outcomes require commitment to dietary modifications and increased physical activity alongside medication. NICE recommends prescription diet injections as part of a multi-component intervention including behavioural support, nutritional guidance, and exercise programmes [5]. Our clinical team provides ongoing support throughout your treatment, with prescribers available to adjust doses, manage side effects, or discuss progress during follow-up consultations at no additional cost.

What to Expect in Your First Month

During the initial four weeks, you'll follow a low starting dose designed to minimise side effects whilst your body adapts to treatment. Mild nausea or changes in bowel habits are common during this period and typically resolve within 2-3 weeks. Weight loss during the first month is often modest (1-2kg on average), with more significant reductions occurring as doses increase and metabolic adaptations develop. Keeping a symptom diary helps identify patterns and informs discussions with your prescriber about dose escalation timing. Most patients find side effects manageable with simple strategies including smaller meal portions, avoiding high-fat foods, and staying well-hydrated throughout the day.

Scientific References

1. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–218. https://doi.org/10.1056/NEJMoa2206038
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892
5. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, lifestyle modifications, and individual metabolic factors.